Clinical Trial Update: Phase II Study of Daily Adaptive Radiotherapy for Submandibular Gland-sparing in Head and Neck Cancer [NA]

View source ↗

Summary

This clinical trial update describes a Phase II study of daily adaptive radiotherapy to spare the submandibular gland during treatment of head and neck squamous…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Squamous Cell Cancer of Head and Neck (SCCHN) | NA | Status: RECRUITING